Abbott has entered into a first-of-its-kind agreement to integrate data from its FreeStyle Libre continuous glucose monitoring (CGM) systems directly into Epic's electronic health record (EHR) systems in the United States. The collaboration, announced on April 29, 2025, aims to streamline access to critical glucose data for healthcare organizations and improve workflow efficiency for providers.
Through this integration, data from a user's LibreView account will be automatically linked to Epic's systems, allowing clinicians to view patients' glucose data within Epic before, during, and after patient consultations. This seamless process ensures healthcare providers can access key glucose information directly within their preferred workflows, enabling more informed care decisions.
Expanding Access to Critical Diabetes Data
The integration will connect more than 575,000 U.S. healthcare providers serving approximately 280 million patients to critical glucose data in their patients' electronic charts. This connection is designed to help clinicians spend less time searching for data and more time on patient care management.
Lisa Earnhardt, Executive Vice President and Group President of Medical Devices for Abbott, emphasized the company's broader vision: "Our goal is to simplify care and drive better outcomes for both providers and patients. While the integration with Libre data is Abbott's first medical device offering with Epic, it's just the beginning. We aim to expand this model to our other medical devices and connected care platforms in the future."
The collaboration leverages Epic's Aura software, which brings health systems together with diagnostics labs and medical device manufacturers. Epic is the leading U.S. provider of EHR software, having achieved its largest ever net gain in hospital market share last year according to Klas Research.
Addressing a Major Healthcare Challenge
The integration addresses a significant healthcare need in the United States, where nearly 40 million people live with diabetes.
"Diabetes requires close collaboration between patients, primary care providers, and specialists to manage a complex and time-critical care plan," said Alan Hutchison, Vice President at Epic. "This will help everyone focus more on patient care and less on administrative hurdles."
Studies have shown that the use of CGM technology can lead to improved patient engagement and behavior change. By making this data more accessible within existing clinical workflows, the integration aims to enhance the collaborative relationship between patients and their healthcare providers.
Market Leadership and Future Expansion
Abbott's FreeStyle Libre portfolio has revolutionized diabetes care over the past decade and is now used by more than 7 million people across over 60 countries. The company reported CGM sales of $1.7 billion in the first quarter of the year, representing 18.3% year-over-year growth on a reported basis.
The integration with Epic represents a strategic move in the competitive CGM market. Dexcom, another major player specializing in CGMs, has forecast sales of $4.6 billion this year.
Healthcare providers and health system administrators interested in receiving future updates on this integration can contact Abbott's diabetes care business at Libre.Epic@abbott.com.
Implications for Digital Health Integration
This partnership highlights the growing importance of interoperability in healthcare technology. By connecting specialized medical devices with mainstream electronic health record systems, companies like Abbott and Epic are addressing one of the persistent challenges in healthcare delivery: fragmented data systems that create barriers to comprehensive patient care.
The collaboration also demonstrates how digital health integration can potentially improve clinical outcomes by providing healthcare professionals with more complete and accessible patient information at the point of care. As this model expands to include other medical devices and connected care platforms, it could significantly enhance the efficiency and effectiveness of healthcare delivery for patients with chronic conditions.
